CD79A and COVID-19: Instead, recent data show that understanding the dynamics of salivary IgA levels following the booster dose of the anti-SARS-CoV-2 vaccine may provide valuable insights into the mucosal immune response and its potential contribution to enhanced protection against the onset of COVID-19 [22].